Escherichia coliKlebsiella speciesEnterobacter speciesHaemophilus influenzaMorganella morganiiProteus mirabilisProteus vulgarisShigella flexneriShigella sonnei. Approximately 44% of trimethoprim and 70% of sulfamethoxazole are bound to plasma proteins. The free forms of sulfamethoxazole and trimethoprim are considered to be the therapeutically activeforms. Oct 1988;44(4):467-77. Pharmacokinetics of the trimethoprim-sulfamethoxazole combination in the elderly. The trimethoprim component of Septra may cause hyperkalemia when administered to patients with underlying disorders of potassium metabolism, with renal insufficiency, or when given concomitantly with drugs known to induce hyperkalemia, such as angiotensin converting enzyme inhibitors. The patient should be monitored with blood counts and appropriate blood chemistries, including electrolytes. An identical daily dosage is used for 5 days in the treatment of shigellosis. A simulation conducted with data from a pharmacokinetic study in 153 infants and children demonstrated that mean steady state AUC and maximum plasma concentrations of trimethoprim and sulfamethoxazole would be comparable between pediatric patients 2 months to 18 years receiving 8/40 (trimethoprim/sulfamethoxazole) mg/kg/day divided every 12 hours and adultpatients receiving 320/1600 (trimethoprim/sulfamethoxazole) mg/day. WARNINGS Increased digoxin blood levels can occur with concomitant SEPTRA therapy, especially in elderly patients. Each SEPTRA Tablet contains 80 mg trimethoprim and 400 mg sulfamethoxazole and the inactive ingredients docusate sodium (0.4 mg per tablet), FD&C Red No. Septra is also contraindicated in pregnant patients at term and in nursing mothers, because sulfonamides pass the placenta and are excreted in the milk and may cause kernicterus. Trimethoprim is 5-[(3,4,5-trimeth-oxyphenyl)methyl]-2,4- pyrimidinediamine. The mean serum half-lives of sulfamethoxazole and trimethoprim are 10 and 8 to 10 hours, respectively. These studies are further limited by recall, selection, and information biases, and by limited generalizability of their findings.Lastly, outcome measures varied between studies, limiting cross-study comparisons. Brumfitt W, Pursell R. Trimethoprim-sulfamethoxazole in the treatment of bacteriuria in women. SEPTRA, specifically the trimethoprim component, can interfere with a serum methotrexate assay as determined by the competitive binding protein technique (CBPA) when a bacterial dihydrofolate reductase is used as the binding protein. The recommended dose for pediatric patients with urinary tract infections or acute otitis media is 8 mg/kg trimethoprim and 40 mg/kg sulfamethoxazole per 24 hours, given in two divided doses every 12 hours for 10 days. While there are no large, well-controlled studies on the use of trimethoprim and sulfamethoxazole in pregnant women, Brumfitt and Pursell,6 in a retrospective study, reported the outcome of 186 pregnancies during which the mother received either placebo or trimethoprim and sulfamethoxazole. Patients with renal dysfunction, liver disease, malnutrition or those receiving high doses of SEPTRA are particularly at risk. Suspensions should be stored at 15 to 25C (59 to 77F) and protected from light. Margassery S, Bastani B. The presence of 10 mg percent sulfamethoxazole in plasma decreases the protein binding of trimethoprim by an insignificant degree; trimethoprim does not influence the protein binding of sulfamethoxazole. The incidence of hyperkalemia and hyponatremia appears to be increased in AIDS patients receiving Septra. This interaction should be kept in mind when SEPTRA is given to patients already on anticoagulant therapy, and the coagulation time should be reassessed. Hepatitis, including cholestatic jaundice and hepatic necrosis, elevation of serum transaminase and bilirubin, pseudo-membranous enterocolitis, pancreatitis, stomatitis, glossitis, nausea, emesis, abdominal pain, diarrhea, anorexia. Sometimes after starting treatment with antibiotics, patients can develop watery and bloody stools (with or without stomach cramps and fever) even as late as two or more months after having taken the last dose of the antibiotic. Sulfamethoxazole and trimethoprim may cause birth defects. However, afternormalizing by body weight,theapparenttotalbody clearance of trimethoprim was an average 19% lower in geriatric subjects compared with young adult subjects.3. The sulfonamides bear certain chemical similarities to some goitrogens, diuretics (acetazolamide and the thiazides), and oral hypoglycemic agents. Sulfamethoxazole was not carcinogenic when assessed in a 26-week tumorigenic mouse (TgrasH2) study at doses up to 400 mg/kg/day sulfamethoxazole; equivalent to 2.4-fold the human systemic exposure (at a daily dose of 800 mg sulfamethoxazole b.i.d.). Excretion of sulfamethoxazole and trimethoprim is primarily by the kidneys through both glomerular filtration and tubular secretion. Prescribing Septra in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria. In rats, oral doses of either 533 mg/kg sulfamethoxazole or 200 mg/kg trimethoprim produced teratologic effects manifested mainly as cleft palates. In studies at two laboratories, no chromosomal damage was detected in cultured Chinese hamster ovary cells at concentrations approximately 500 times human plasma levels; at concentrations approximately 1,000 times human plasma levels in these same cells, a low level of chromosomal damage was induced at one of the laboratories. Both tablet and suspension forms are for oral administration. Although other combinations of sulfonamides are available with trimethoprim, TMP-SMX is by far the most widely used. Urinalyses with careful microscopic examination and renal function tests should be performed during therapy, particularly for those patients with impaired renal function. SEPTRA Tablets contain 1.8 mg (0.08 mEq) of sodium per tablet. General principles of treatment include the institution of gastric lavage or emesis; forcing oral fluids; and the administration of intravenous fluids if urine output is low and renal function is normal. Levels of trimethoprim/sulfamethoxazole in breast milk are approximately 2-5% of the recommended daily dose for infants over 2 months of age. FATALITIES ASSOCIATED WITH THE ADMINISTRATION OF SULFONAMIDES, ALTHOUGH RARE, HAVE OCCURRED DUE TO SEVERE REACTIONS, INCLUDING STEVENS-JOHNSON SYNDROME, TOXIC EPIDERMAL NECROLYSIS, FULMINANT HEPATIC NECROSIS, AGRANULOCYTOSIS, APLASTIC ANEMIA, OTHER BLOOD DYSCRASIAS, AND HYPERSENSITIVITY OF THE RESPIRATORY TRACT (SEE. Sometimes after starting treatment with antibiotics, patients can develop watery and bloody stools (with or without stomach cramps and fever) even as late as two or more months after having taken the last dose of the antibiotic. 1, flavor, glycerin, microcrystalline cellulose, polysorbate 80, saccharin sodium, and sorbitol. A history of mild intolerance to Septra in AIDS patients does not appear to predict intolerance of subsequent secondary prophylaxis. Septra DS Thus, Septra blocks two consecutive steps in the biosynthesis of nucleic acids and proteins essential to many bacteria. 400 mg sulfamethoxazole. 80 mg trimethoprim and It has been reported that Septra may prolong the prothrombin time in patients who are receiving the anticoagulant warfarin. Use of Septra at high doses and/or for extended periods of time may cause bone marrow depression manifested as thrombocytopenia, leukopenia, and/or megaloblastic anemia. 9. Brumfitt W, Pursell R. Trimethoprim-sulfamethoxazole in the treatment of bacteriuria in women. This product is available in the following dosage forms: Tablet; Suspension The trimethoprim component of SEPTRA may cause hyperkalemia when administered to patients with underlying disorders of potassium metabolism, with renal insufficiency, or when given concomitantly with drugs known to induce hyperkalemia, such asangiotensin converting enzymeinhibitors.5 Closemonitoring of serum potassium is warranted in these patients. If a significant blood dyscrasia or jaundice occurs, specific therapy should be instituted for these complications. 1. In addition, periarteritis nodosa and systemic lupuse rythematosus have been reported. Last reviewed on RxList: 5/25/2022 Trimethoprim increases the plasma concentrations of procainamide and its active #-acetyl metabolite (NAPA) when trimethoprim and procainamide are co-administered. J. Nephrol. The amount of a single dose of SEPTRA that is either associated with symptoms of overdosage or is likely to be life-threatening has not been reported. Blood dyscrasias and jaundice are potential late manifestations of overdosage. Peritoneal dialysis is not effective and hemodialysis is only moderately effective in eliminating trimethoprim and sulfamethoxazole. Hepatitis, including cholestatic jaundice and hepatic necrosis, elevation of serum transaminases and bilirubin, pseudomembranous enterocolitis, pancreatitis, stomatitis, glossitis, nausea, emesis, abdominal pain, diarrhea, anorexia. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. What Are Drug Interactions? This medicine is available only with your doctor's prescription. Hypertoxin producing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. While there are no large, well-controlled studies on the use of trimethoprim and sulfamethoxazole in pregnant women, Brumfitt and Pursell,11 in a retrospective study, reported the outcome of 186 pregnancies during which the mother received either placebo or trimethoprim and sulfamethoxazole. When renal function is impaired, a reduced dosage should be employed using the following table: The usual adult dosage in the treatment of acute exacerbations of chronic bronchitis is one SEPTRA DS (double strength) tablet, two SEPTRA tablets, or four teaspoonfuls (20 mL)SEPTRA Suspension every 12 hours for 14 days. In elderly patients concurrently receiving certain diuretics, primarily thiazides, an increased incidence of thrombocytopenia with purpura has been reported. Trimethoprim alters the disposition of procainamide and N-acetylprocainamide. Trimethoprim is available as a single drug or in combination with sulfamethoxazole (a sulfonamide antibiotic Sulfonamides Sulfonamides are synthetic bacteriostatic antibiotics that competitively inhibit conversion of p-aminobenzoic acid to dihydropteroate, which bacteria need for folate synthesis and ultimately. In in vitro and in vivo tests in animal species, sulfamethoxazole/trimethoprim did not damage chromosomes. What Are Common Drug Interactions? For the treatment of documented Pneumocystis carinii pneumonia. The structural formula is: Sulfamethoxazole is 4-amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide. CDAD must be considered in all patients who present with diarrhea following antibiotic use. Occasional reports suggest that patients receiving pyrimethamine as malaria prophylaxis in doses exceeding 25 mg weekly may develop megaloblastic anemia if SEPTRA is prescribed. Some epidemiologic studies suggest that exposure to sulfamethoxazole/trimethoprim during pregnancy may be associated with an increased risk of congenital malformations, particularly neural tube defects, cardiovascular malformations, urinary tract defects, oral clefts, and club foot. The mean maximum serum trimethoprim concentration was higher and mean renal clearance of trimpethoprim was lower in geriatric subjects compared with younger subjects3 (see CLINICAL PHARMACOLOGY: Geriatric Pharmacokinetics). Subscribe to Drugs.com newsletters for the latest medication news, new drug approvals, alerts and updates. In some rabbit studies, an overall increase in fetal loss (dead and resorbed conceptuses) was associated with doses of trimethoprim 6 times the human therapeuticdose based on body surface area. The structural formula is: Sulfamethoxazole is 4-amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide. Trimethoprim-sulfamethoxazole-induced thrombocytopenia may be an immune-mediated disorder. Close monitoring of serum potassium is warranted in these patients. The usual spectrum of antimicrobial activity of Septra includes bacterial pathogens isolated from middle ear exudate and from bronchial secretions (Haemophilus influenzae, including ampicillin-resistant strains, and Streptococcus pneumoniae), and enterotoxigenic strains of Escherichia coli (ETEC) causing bacterial gastroenteritis. The mean renal clearance of trimethoprim was significantly lower in geriatric subjects compared with young adult subjects (19 mL/h/kg vs. 55 mL/h/kg). The pharmacokinetics of sulfamethoxazole 800 mg and trimethoprim 160 mg were studied in 6 geriatric subjects (mean age: 78.6 years) and 6 young healthy subjects (mean age: 29.3 years) using a non-US approved formulation. They do not treat viral infections (e.g., the common cold). (trimethoprim and sulfamethoxazole). In mice following oral administration of trimethoprim, no DNA damage in Comet assays of liver, kidney, lung, spleen, or bone marrow was recorded. The recommended quantitative disc susceptibility method may be used for estimating the susceptibility of bacteria to Septra.4,5 With this procedure, a report from the laboratory of "Susceptible to trimethoprim and sulfamethoxazole" indicates that the infection is likely to respond to therapy with Septra. Patients should be counseled that antibacterial drugs including Septra should only be used to treat bacterial infections. Pharmacokinetics parameters for sulfamethoxazole were similar for geriatric subjects and younger adult subjects. Adjunctive folinic acid with trimethoprim-sulfamethoxazole for Pneumocystis carinii pneumonia in AIDS patients is associated with an increased risk oftherapeutic failure and death. Trimethoprim-sulfamethoxazole (TMP-SMX), also known as co-trimoxazole, is a combination of two antimicrobial agents that act synergistically against a wide variety of bacteria. Urine concentrations of both sulfamethoxazole and trimethoprim are considerably higher than are the concentrations in the blood. Renal failure, interstitial nephritis, BUN and serum creatinine elevation, toxic nephrosis with oliguria and anuria, and crystalluria. Moh R, et al. Check with your physician if you have any of the following: Conditions: diarrhea from an infection with Clostridium difficile bacteria a. The sulfonamides bear certain chemical similarities to some goitrogens, diuretics (acetazolamide and the thiazides), and oral hypoglycemic agents. In vivo micronucleus assays were positive following oral administration of sulfamethoxazole/trimethoprim. SEPTRA is contraindicated in patients with the following: SEPTRA is rapidly absorbed following oral administration. Fatalities associated with the administration of sulfonamides have occurred due to severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome, toxic epidermal necrolysis, and drug reaction with eosinophilia and systemic symptoms(DRESS), fulminant hepatic necrosis, agranulocytosis, aplastic anemia, other blood dyscrasias, acute and delayed lung injury, anaphylaxis, and circulatory shock (see WARNINGS). Diuresis and hypoglycemia have occurred rarely in patients receiving sulfonamides. In addition, periarteritis nodosa and systemic lupus erythematosus have been reported. What dose of co-trimoxazole is used in a patient with a UTI? Adverse effects are generally less severe in patients receiving SEPTRA for prophylaxis. The recommended dosage for prophylaxis in adults is one SEPTRA DS (double strength) tablet daily. If signs of bone marrow depression occur, the patient should be given leucovorin; 5 to 15 mg leucovorin daily has been recommended by some investigators. During pregnancy, Septra should be used only when prescribed. The steady-state minimal plasma levels of free and total sulfamethoxazole were 57.4 mcg/mL and 68.0 mcg/mL, respectively. Tell your doctor if you have serious side effects of Septra including: The dose of Septra varies depending on the condition being treated. Excretion of sulfamethoxazole and trimethoprim is primarily by the kidneys through both glomerular filtration and tubular secretion. Double Strength Kremers P, Duvivier J, Heusghem C. Pharmacokinetic studies of co-trimoxazole in man after single and repeated doses. In glucose-6-phosphate dehydrogenase-deficient individuals, hemolysis may occur. [dosing clarification] Info: dosing based on trimethoprim (TMP) component infections, mild-moderate bacterial [160 mg TMP PO bid] Alt: 8-10 mg/kg/day TMP PO/IV divided q6-12h; Info: dose, duration varies w/ infection type, severity; consider using adjusted wt of IBW + 0.4 x (ABW - IBW) if >8 mg/kg/day in obese pts UTI [mild-moderate infection] SEPTRA (trimethoprim and sulfamethoxazole) is a synthetic antibacterial combination product. Each SEPTRA DS (double strength) tablet contains 160 mg trimethoprim and 800 mg sulfamethoxazole and the inactive ingredients docusate sodium (0.8 mg per tablet), FD&C Red No. There were no abnormalities in the 10 children whose mothers received the drug during the first trimester. Clostridium difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including Septra, and may range in severity from mild diarrhea to fatal colitis. 40, magnesium stearate, povidone, and sodium starch glycolate. Septra may inhibit the hepatic metabolism of phenytoin. This reaction is frequently dose-related (see CLINICAL PHARMACOLOGY and DOSAGE AND ADMINISTRATION). Description Clinical Pharmacology Indications and Usage Contraindications Warnings Precautions Patient Counseling Information Drug Interactions Adverse Reactions/Side Effects Overdosage Dosage and Administration How Supplied/Storage and Handling References Rx only Septra DS Tablets contain 3.6 mg (0.16 mEq) of sodium per tablet. 8. Signs and symptoms of overdosage reported with sulfonamides include anorexia, colic, nausea, vomiting, dizziness, headache, drowsiness, and unconsciousness. Al-Khatib SM, LaPointe N, Kramer JM, Califf RM. Pharmacokinetics of the trimethoprim-sulfamethoxazole combination in the elderly. During administration of 160 mg trimethoprim and 800 mg sulfamethoxazole b.i.d., the mean steady-state plasma concentration of trimethoprim was 1.72 mcg/mL. The following table is a guideline for the attainment of this dosage in pediatric patients: TABLETS (pink, scored, round-shaped) containing 80 mg trimethoprim and 400 mg sulfamethoxazole: Bottles of 100 (NDC 61570-052-01). The efficacy of tricyclic antidepressants can decrease when co-administered with SEPTRA. Treatment failure and excess mortality were observed when trimethoprim-sulfamethoxazole was used concomitantly with leucovorin for the treatment of HIV positive patients with Pneumocystis jirovecii pneumonia in a randomized placebo controlled trial.4 Co-administration of trimethoprim-sulfamethoxazole and leucovorin during treatment of Pneumocystis jirovecii pneumonia should be avoided. Gerontology 45: 209-212, 1999. This interaction should be kept in mind when Septra is given to patients already on anticoagulant therapy, and the coagulation time should be reassessed. Appropriate fluid and electrolyte management, protein supplementation, antibiotic treatment of C. difficile, and surgical evaluation should be instituted as clinically indicated. Imprint on tablets M052. 40, magnesium stearate, povidone, and sodium starch glycolate. Double Strength AIDS patients may not tolerate or respond to SEPTRA it the same manner as non-AIDS patients. Review: The Pharmacology and Toxicology of Dofetilide. Carcinogenesis: Long-term studies in animals to evaluate carcinogenic potential have not been conducted with Septra. Septra Tablets contain 1.8 mg (0.08 mEq) of sodium per tablet. The average percentage of the dose recovered in urine from 0 to 72 hours after a single oral dose is 84.5% for total sulfonamide and 66.8% for free trimethoprim. The metabolism of sulfamethoxazole occurs predominately by N4-acetylation, although the glucuronide conjugate has been identified. The free forms of sulfamethoxazole and trimethoprim are considered to be the therapeutically active forms. 3. It will not work for viral infections (such as flu ). RxList does not provide medical advice, diagnosis or treatment. In the literature, two cases of hyperkalemia in elderly patients have been reported after concomitant intake of trimethoprim/sulfamethoxazole and an angiotensin converting enzyme inhibitor. CONTRAINDICATIONS. Pharmacokinetic values for sulfamethoxazole in geriatric subjects were similar to those observed in young adult subjects. The average percentage of the dose recovered in urine from 0 to 72 hours after a single oral dose of sulfamethoxazole and trimethoprim is 84.5% for total sulfonamide and 66.8% for free. Hematological changes indicative of folic acid deficiency may occur in elderly patients. No interference occurs, however, if methotrexate is measured by a radioimmunoassay (RIA). Signs of acute overdosage with trimethoprim include nausea, vomiting, dizziness, headache, mental depression, confusion, and bone marrow depression. Adjunctive folinic acid with trimethoprim-sulfamethoxazole for. No interference occurs, however, if methotrexate is measured by a radioimmunoassay (RIA). Each scored tablet contains Cross-sensitivity may exist with these agents. If sulfamethoxazole/trimethoprim is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be advised of the potential hazards to the fetus. Even treatment with recommended doses may cause hyperkalemia when trimethoprim is administered to patients with underlying disorders of potassium metabolism, with renal insufficiency, or if drugs known to induce hyperkalemia are given concomitantly. During administration of 160 mg trimethoprim and 800 mg sulfamethoxazole b.i.d., the mean steady-state plasma concentration of trimethoprim was 1.72 mcg/mL. Each Septra DS (double strength) Tablet contains 160 mg trimethoprim and 800 mg sulfamethoxazole and the inactive ingredients docusate sodium (0.8 mg per tablet), FD&C Red No. Do not use it if you had an allergic reaction to trimethoprim, sulfamethoxazole, or any sulfa drug. Medically reviewed by Drugs.com. The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Marinella MA. Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. sulfamethoxazole). The structural formula is: Septra is rapidly absorbed following oral administration. Both sulfamethoxazole and trimethoprim exist in the blood as unbound, protein-bound, and metabolized forms; sulfamethoxazole also exists as the conjugated form. SEPTRA should not be used for the treatment of group A beta-hemolytic streptococcal infections. The mean maximum serum trimethoprim concentration was higher and mean renal clearance of trimpethoprim was lower in geriatric subjects compared with younger subjects3 (see CLINICAL PHARMACOLOGY: Geriatric Pharmacokinetics:). Increased digoxin blood levels can occur with concomitant SEPTRA therapy, especially in elderly patients.Serum digoxin levels should be monitored. Marinella MA. Clostridioides difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including SEPTRA, and may range in severity from mild diarrhea to fatal colitis. 11. C. difficile produces toxins A and B which contribute to the development of CDAD. Both trimethoprim and sulfamethoxazole distribute to sputum, vaginal fluid, and middle ear fluid;trimethoprim also distributes to bronchial secretions, and both pass the placental barrier and are excreted in human milk. Each scored tablet contains An in vitro chromosomal aberration test in human lymphocytes with sulfamethoxazole/trimethoprim was negative. For the treatment of documented Pneumocystis jirovecii pneumonia. This monograph has been modified to include the generic and brand name in many instances. This medicine will not work for colds, flu, or other virus infections. The following table is a guideline for the attainment of this dosage: Pediatric Patients: Two Months of Age or Older. The FDA-Approved indications include acute infective exacerbation of chronic bronchitis, otitis media in pediatrics only, travelers diarrhea for treatment and prophylaxis, urinary tract infections, shigellosis, pneumocystis jirovecii, pneumonia/pneumocystis carinii pneumonia (PJP/PCP), and toxoplasmosis, both as prophylaxis and treatment. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. 7. Agranulocytosis, aplastic anemia, thrombocytopenia, leukopenia, neutropenia, hemolytic anemia, megaloblastic anemia, hypoprothrombinemia, methemoglobinemia, eosinophilia. For the treatment of acute exacerbations of chronic bronchitis due to susceptible strains of Streptococcus pneumoniae or Haemophilus influenzae when, in the judgment of the physician, Septra offers some advantage over the use of a single antimicrobial agent. Copyright 2023 by RxList Inc. An Internet Brands company. For the treatment of acute otitis media in pediatric patients due to susceptible strains of Streptococcus pneumoniae or Haemophilus influenzae when, in the judgment of the physician, SEPTRA offers some advantage over the use of other antimicrobial agents. Each Septra Tablet contains 80 mg trimethoprim and 400 mg sulfamethoxazole and the inactive ingredients docusate sodium (0.4 mg per tablet), FD&C Red No. QT prolongation resulting in ventricular tachycardia and torsade de pointes, circulatory shock. In an established infection, they will not eradicate the streptococcus and, therefore, will not prevent sequelae such as rheumatic fever. Trimethoprim blocks the production of tetrahydrofolic acid from dihydrofolic acid by binding to and reversibly inhibiting the required enzyme, dihydrofolate reductase. read more ).The drugs act synergistically to block sequential steps in bacterial . Peak blood levels for the individual components occur 1 to 4 hours after oral administration. C. difficile produces toxins A and B which contribute to the development of CDAD. Indications Dosage and Administration Contraindications Boxed Warnings Warnings/Precautions Pharmacokinetics Interactions Adverse Reactions Clinical Trials Note Patient Counseling Bactrim. In an established infection, SEPTRA will not eradicate the Streptococcus and, therefore, will not prevent sequelae such as rheumatic fever. Data sources include IBM Watson Micromedex (updated 14 May 2023), Cerner Multum (updated 28 May 2023), ASHP (updated 10 Apr 2023) and others. Sulfamethoxazole inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid (PABA). SEPTRA may inhibit the hepatic metabolism of phenytoin (a CYP2C9 substrate). The patient should be monitored with blood counts and appropriate blood chemistries, including electrolytes. Antibiotic susceptibility discs; certification procedure. In two studies in rats, no teratology was observed when 512 mg/kg of sulfamethoxazole was used in combination with 128 mg/kg of trimethoprim. In some rabbit studies, an overall increase in fetal loss (dead and resorbed and malformed conceptuses) was associated with doses of trimethoprim six times the human therapeutic dose. See additional information. However, if a patient develops skin rash or any sign of adverse reaction, therapy with Septra should be re-evaluated (see WARNINGS). 2003;289(16):2120-2127. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile. What Drugs Can You Not Take Together? 6 sulfamethoxazole/trimethoprim interactions to know about Bactrim can change how your liver breaks down (metabolizes) certain medications and substances. In vitro reverse mutation bacterial tests according to the standard protocol have not been performed with sulfamethoxazole and trimethoprim in combination. Appropriate dosage adjustments should be made for patients with impaired kidney function and duration of use should be as short as possible to minimize risks of undesired reactions (see DOSAGE AND ADMINISTRATION section). Drug class: Sulfonamides. Shigella flexneri and Shigella sonnei are also usually susceptible. Caution is recommended when SEPTRA is co-administered with drugs that are substrates of CYP2C8 and 2C9 or OCT2. They do not treat viral infections (e.g., the common cold). Tell your doctor all medications you use. Septra, given at a common clinical dosage, increased the phenytoin half-life by 39% and decreased the phenytoin metabolic clearance rate by 27%. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Septra and other antibacterial drugs, Septra should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. Urinary Tract Infections and Shigellosis in Adults and Pediatric Patients and Acute Otitis Media in Pediatric Patients: Adults: The usual adult dosage in the treatment of urinary tract infections is one SEPTRA DS (double strength) tablet, two SEPTRA tablets, or four teaspoonfuls (20 mL) SEPTRA Suspension every 12 hours for 10 to 14 days. These doses are approximately 5 and 6 times the recommended human total daily dose on a body surface area basis. For the treatment of travelers' diarrhea, the usual adult dosage is one Septra DS (double strength) tablet, two Septra tablets, or four teaspoonfuls (20 mL) of Septra Suspension every 12 hours for 5 days. read more ).The drugs act synergistically to block sequential steps in bacterial . Explore careers. signs of low blood sugar (such as nervousness, shakiness, sweating, hunger). The concomitant use of leucovorin with trimethoprim-sulfamethoxazole for the acute treatment of Pneumocystis carinii pneumonia in patients with HIV infection was associated with increased rates of treatment failure and morbidity in a placebo-controlled study. The average percentage of the dose recovered in urine from 0 to 72 hours after a single oral dose is 84.5% fortotal sulfonamide and 66.8% for free trimethoprim. Detectable amounts of trimethoprim and sulfamethoxazole are present in the blood 24 hours after drug administration. About this Site. 1974;5:439-443. Renal failure, interstitial nephritis, BUN and serum creatinine elevation, renal insufficiency, anuria, crystalluria, and nephrotoxicity in association with cyclosporine. In a separate survey, Brumfitt and Pursell also found no congenital abnormalities in 35 children whose mothers had received oral trimethoprim and sulfamethoxazole at the time ofconception or shortly thereafter. To date, there is limited data on the safety of repeated use of Septra in pediatric patients under two years of age. SEPTRA should be discontinued at the first appearance of skin rash or any sign of a serious adverse reaction. In those concurrently receiving certain diuretics, primarily thiazides, an increased incidence of thrombocytopenia with purpura has been reported. An identical daily dosage is used for 5 days in the . It is recommended that initial episodes of uncomplicated urinary tract infections be treated with a single effective antibacterial agent rather than the combination. Increased digoxin blood levels can occur with concomitant Septra therapy, especially in elderly patients. DESCRIPTION BACTRIM (sulfamethoxazole and trimethoprim) is a synthetic antibacterial combination product available in DS (double strength) tablets, each containing 800 mg sulfamethoxazole and. Septra, specifically the trimethoprim component, can interfere with a serum methotrexate assay as determined by the competitive binding protein technique (CBPA) when a bacterial dihydrofolate reductase is used as the binding protein. Isolated cases of rhabdomyolosis have been reported with Septra, mainly in AIDS patients. The presence of trimethoprim and sulfamethoxazole may also interfere with the Jaff alkaline picrate reaction assay for creatinine, resulting in overestimations of about 10% in the range of normal values. The recommended dosage for treatment of patients with documented P jirovecii pneumonia is 15 to 20 mg/kg trimethoprim and 75 to 100 mg/kg sulfamethoxazole per 24 hours given in equally divided doses every 6 hours for 14 to 21 days. If CDAD is suspected or confirmed, ongoing antibiotic use not directed against C. difficile may need to be discontinued. Boyer EW, Stork C, Wang RY. Arthralgia and myalgia. The incidence of congenital abnormalities was 4.5% (3 of 66) in those who received placebo and 3.3% (4 of 120) in those receiving trimethoprim and sulfamethoxazole.There were no abnormalities in the 10 children whose mothers received the drug during the first trimester. Arthralgia and myalgia. Hallucinations, depression, apathy, nervousness. Clinical studies of SEPTRA did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Severe skin reactions, generalized bone marrow suppression (see WARNINGS and ADVERSE REACTIONS sections), a specific decrease in platelets (with or without purpura), and hyperkalemia are the most frequently reported severe adverse reactions in elderly patients. In rare instances, a skin rash may be followed by a more severe reaction, such as Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS, AGEP, or AFND, hepatic necrosis, and serious blood disorders (see PRECAUTIONS and ADVERSE REACTIONS). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. Overview sulfamethoxazole sulfonamide Interaction Characteristics: CYP2C9 inhibitor, weak affected by delayed gastric emptying alters GI flora hypoglycemic effects impairs immunomodulatory bacterial infective agent methemoglobinemia photosensitivity trimethoprim Closemonitoring of serum potassium is warranted in these patients. Sulfamethoxazole inhibits bacterial synthesis of dihydrofolic acid by competing with paraaminobenzoic acid (PABA). Concurrent administration is contraindicated, Elevated plasma concentrations of dofetilide have been reported following concurrent administration of trimethoprim and dofetilide. It is recommended that initial episodes of uncomplicated urinary tract infections be treated with a single effective antibacterial agent rather than the combination. Clinical studies of Septra did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. You have to notify your physician prescribing you Bactrim of the reality of planning or taking on taking seizure medicines, diuretics, methotrexate, blood slimmers, or ACE inhibitors.
How To Know Wifi Password Without Qr Code, Chronocyclegraph Definition, Vibraphone Motor Speeds, 5 Letter Words That Rhyme With Water, Island Pond Vt Real Estate Waterfront, 2014 Ford Fiesta Titanium Specs, Search Me, O God, And Know My Heart Verse, Dot Operator Example In Java, Bbau Admission Form 2022-23 Date Pg, Best Beach Resorts Near Hanoi, Mysql Datetime To Unix Timestamp, Mail Merge Not Working In Word, Excel Not Printing All Columns, Change Timezone Mysql Workbench,